healthrx.com

Can I Take Creatine with Spironolactone?

Clinical medical image for supplements spironolactone acne: Can I Take Creatine with Spironolactone?
Image: HealthRX.com clinical illustration

Spironolactone (brand names Aldactone, CaroSpir) is a potassium-sparing diuretic and aldosterone-receptor antagonist. It is FDA-approved for hypertension, heart failure, and edema, and is widely prescribed off-label for hormonal acne and hirsutism in women, usually at 25-200 mg/day. Creatine monohydrate is a nitrogen-containing compound stored in skeletal muscle and sold as a sports and fitness supplement, most commonly at 3-5 g/day maintenance doses or a short higher-dose loading phase.

There is no known pharmacokinetic interaction between creatine and spironolactone. They are not processed by the same liver enzymes, and creatine does not alter how spironolactone is absorbed or cleared. The real issue is pharmacodynamic and diagnostic: creatine supplementation raises serum creatinine, a lab value your prescriber already monitors closely on spironolactone, and an undisclosed creatinine rise from creatine can be mistaken for a drug-related decline in kidney function. Taking the two together is not considered contraindicated, but disclosure to your prescriber and a follow-up lab check are the practical safeguards.

What kind of interaction is this, really?

It helps to separate two different questions that often get conflated:

  1. Does creatine change spironolactone's effect in the body? No evidence supports this. Creatine is absorbed via intestinal creatine transporters and stored in muscle; spironolactone is metabolized in the liver to active metabolites including canrenone. These are separate pathways. The FDA's drug interaction substrate/inhibitor/inducer table does not list creatine as an interacting substance for spironolactone-relevant enzymes.

  2. Does creatine make spironolactone monitoring harder to interpret? Yes, plausibly. Both spironolactone therapy and creatine supplementation touch the same lab value, serum creatinine, through completely different mechanisms, and a clinician who does not know you take creatine may misread the trend.

Why does spironolactone require creatinine and potassium monitoring in the first place?

Spironolactone blocks aldosterone receptors in the distal nephron, which reduces sodium reabsorption and also reduces potassium and hydrogen ion excretion. At the doses used for heart failure and hypertension, cardiology guidelines call for baseline and periodic serum creatinine and potassium checks because reduced renal perfusion or impaired filtration changes how the drug is cleared and increases hyperkalemia risk. At the lower doses typically used for acne (50-100 mg/day) in young women with normal kidney function, the hemodynamic effect on filtration is generally smaller, but periodic renal and electrolyte monitoring is still standard dermatologic practice. The exact monitoring interval varies by indication and by prescriber, and readers should follow their own prescriber's schedule rather than a generic one.

Why does creatine raise serum creatinine, and does that mean kidney damage?

Creatine (the supplement) and creatinine (the lab value) are related but different substances. A portion of the creatine stored in muscle is continuously converted to creatinine through a non-enzymatic process, and that creatinine is filtered by the kidney and appears in blood and urine. When someone increases their muscle creatine pool through supplementation, more substrate is available for this conversion, and serum creatinine rises, independent of any change in actual kidney filtration.

Small studies in healthy adults have reported measurable, reversible increases in serum creatinine during creatine loading (commonly cited protocols use around 20 g/day for several days), with values returning to baseline after supplementation stops. The precise magnitude reported varies by study and dosing protocol, and readers who want an exact figure for a specific dose should verify it against the primary literature rather than rely on a single number repeated across secondary sources.

Longer-term evidence in healthy, exercising adults has generally not shown a decline in measured glomerular filtration when cystatin C, a creatinine-independent marker of kidney function, is used instead of standard serum creatinine. This distinction matters specifically because cystatin C is not affected by muscle creatine content, so it is the more reliable marker when creatine supplementation is confounding a standard creatinine reading.

What is not established: long-term creatine safety data in people simultaneously taking a potassium-sparing diuretic like spironolactone have not been specifically studied in controlled trials. The reassurance about creatine and kidney function comes from studies of creatine alone, not from a population also taking spironolactone. Extrapolating full safety to the combined scenario is reasonable but not directly proven.

Who should be more cautious about this combination?

  • Anyone with an eGFR below 60 mL/min/1.73m², a single functioning kidney, or polycystic kidney disease should discuss creatine with a nephrologist or their prescribing clinician before starting, independent of spironolactone use, because a rising creatinine is harder to interpret when baseline filtration is already reduced.
  • Anyone on spironolactone for heart failure or at cardioprotective doses, where creatinine and potassium are watched more closely and where reduced renal perfusion is common, should raise creatine use directly with their cardiologist rather than deciding independently.
  • Adolescents on spironolactone for severe acne: creatine has less safety data in people under 18, and this combination should be discussed with the prescribing pediatric dermatologist or endocrinologist rather than assumed safe by extension from adult data.

Does creatine affect potassium, the other lab spironolactone monitors?

No mechanism links creatine to potassium handling. Spironolactone's most acutely dangerous effect is hyperkalemia, caused by reduced potassium excretion in the distal nephron; this risk comes from the drug itself, not from any supplement interaction with creatine. Pure creatine monohydrate powder contains no potassium. Combination pre-workout or recovery products sometimes add electrolytes, including potassium, so check the label on blended products rather than assuming all "creatine supplements" are equivalent.

Other substances are more relevant to potassium risk on spironolactone: potassium-containing salt substitutes, high-dose potassium supplements, NSAIDs, and concurrent ACE inhibitors or ARBs. Separately, some herbal preparations containing licorice-like compounds have been reported to cause pseudoaldosteronism, with hypokalemia, metabolic alkalosis, and occasionally rhabdomyolysis, the opposite electrolyte pattern from spironolactone's hyperkalemia risk, and unrelated to creatine (Sasaki et al., 2009). The point for a spironolactone patient is broader than creatine alone: disclose every supplement, not just creatine, because different products carry different and sometimes opposite electrolyte risks.

Evidence-status assessment: creatine plus spironolactone

ClaimEvidence statusWhat a clinician or pharmacist should verify
Creatine and spironolactone share no metabolic (CYP) pathwayEstablished, mechanistically distinct absorption, storage, and metabolism routes; no listed interaction in FDA substrate/inhibitor/inducer resourcesConfirm no new interaction has been added to current drug interaction databases at time of prescribing
Creatine supplementation raises serum creatinine without reflecting true GFR decline, in healthy adultsEstablished in principle, supported by studies using creatine-independent markers (cystatin C)Confirm current cystatin C or eGFR if creatinine rises unexpectedly, rather than assuming benign artifact by default
The specific magnitude of creatinine rise (e.g., ~0.2 mg/dL with a loading dose)Reported in small studies; exact figures vary by protocol and are not verified against a single confirmed source in this reviewCheck current primary literature or a clinical pharmacist reference before using a specific number in patient counseling
Creatine is safe long-term in healthy adults not on any diureticSupported by observational and trial data over months to yearsConfirm the patient's specific health status matches the studied population (age, kidney function, absence of other renal-affecting drugs)
Creatine is safe long-term specifically in people concurrently taking spironolactoneNot established, no dedicated trials in this combined population identifiedTreat as plausible extrapolation, not proven safety; monitor rather than assume
Creatine affects potassium handling or worsens spironolactone-related hyperkalemia riskNot established; no proposed mechanism and no supporting reportsVerify supplement is plain creatine monohydrate, not a blended product with added electrolytes
Spironolactone dose for acne needs adjustment because of creatine use aloneNot established; creatine-related creatinine rise is not itself a spironolactone toxicity signalDistinguish artifact from true renal change using cystatin C or a repeat creatinine after a supplement-free interval before adjusting dose

Practical steps if you want to take both

  1. Tell your prescriber before starting creatine, or as soon as possible if you already take it. This is the single highest-value step, since it changes how any future creatinine reading gets interpreted.
  2. Get a creatinine and potassium check before starting if you have not had one recently, so there is a documented baseline free of creatine's effect.
  3. Consider skipping the high-dose loading phase. A steady 3-5 g/day approach reaches full muscle saturation over roughly a month with a smaller, more gradual effect on serum creatinine than a several-day loading protocol, which may make lab interpretation easier, though exact comparative figures should be confirmed with a pharmacist or sports medicine reference.
  4. Recheck creatinine around 4 weeks after starting creatine, ideally folded into a monitoring visit you already have scheduled for spironolactone.
  5. If creatinine rises unexpectedly, ask about a cystatin C-based eGFR before assuming a true decline in kidney function, and do not adjust or stop spironolactone on your own based on a creatinine number alone.
  6. Dose timing does not matter for this pair. No pharmacokinetic interaction has been identified, so there is no documented reason to separate creatine and spironolactone by time of day.

When to seek urgent care

Creatine and spironolactone together are not an emergency combination for a healthy adult with normal kidney function. Seek prompt medical attention if you develop symptoms suggestive of hyperkalemia (muscle weakness, irregular heartbeat, palpitations) or signs of acute kidney injury (a sharp drop in urine output, significant swelling, confusion), since these reflect spironolactone's known risks rather than anything specific to creatine. A rising creatinine number alone, in the absence of these symptoms, is a reason to call your prescriber and get a follow-up lab, not a reason to go to urgent care.

What is established, what is plausible, and what is not established

Established: creatine and spironolactone do not share a metabolic pathway; creatine reliably raises serum creatinine through a substrate effect rather than kidney injury in healthy people; spironolactone requires periodic creatinine and potassium monitoring because of its mechanism in the distal nephron.

Plausible but not directly tested: that creatine's favorable long-term renal safety profile, established in creatine-only studies, extends fully to people concurrently taking a potassium-sparing diuretic. No dedicated trial of this combination was identified for this review.

Not established: any interaction that would require dose separation, dose adjustment of spironolactone because of creatine use alone, or an added potassium risk from creatine. None of these are supported by current evidence or mechanism.

Frequently asked questions

Can I take creatine while on spironolactone?
Available evidence does not describe a contraindication. Creatine and spironolactone act through unrelated pathways. The practical issue is that creatine raises serum creatinine independent of kidney function, which can confuse the monitoring your spironolactone prescriber relies on, so disclosure and a follow-up lab check are the recommended steps rather than avoidance.
Will creatine make it look like spironolactone is harming my kidneys?
It can, if your prescriber does not know you are taking creatine. A creatinine rise from creatine reflects a larger muscle substrate pool, not reduced filtration. Telling your prescriber, and using a creatinine-independent marker such as cystatin C if a rise is unexpected, helps distinguish artifact from true change.
Does creatine affect potassium levels on spironolactone?
No mechanism links creatine to potassium handling, and pure creatine monohydrate contains no potassium. Spironolactone's hyperkalemia risk comes from the drug's effect on the kidney, not from any interaction with creatine. Check labels on blended supplement products, since some add electrolytes.
Do I need to stop creatine before a blood test while on spironolactone?
Ask your prescriber. Stopping creatine for a couple of weeks before a lab draw lets creatinine return to your supplement-free baseline, which some clinicians prefer for a cleaner reading. Alternatively, if the clinician knows you take creatine regularly, they can simply track your on-creatine baseline over time instead.

References

  1. Sasaki H, et al. Shakuyaku-kanzo-to induces pseudoaldosteronism characterized by hypokalemia, rhabdomyolysis, metabolic alkalosis with respiratory compensation, and increased urinary cortisol levels. 2009. https://pubmed.ncbi.nlm.nih.gov/19388868/

  2. FDA Drug Development and Drug Interactions: Table of Substrates, Inhibitors and Inducers. U.S. Food and Drug Administration. https://www.fda.gov/drugs/drug-interactions-labeling/drug-development-and-drug-interactions-table-substrates-inhibitors-and-inducers

Other specific figures referenced in earlier drafts of this article (exact magnitude of creatinine rise from creatine loading, trial-level efficacy numbers for spironolactone in acne, and specific mortality reduction figures from heart failure trials) require verification against the primary literature before publication and are described in general terms here pending that check.